Comparison of carotid artery stenting results in primary stenosis and post-surgical restenosis

Similar documents
Advances in the treatment of posterior cerebral circulation symptomatic disease

Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

Vascular complications after extracorporeal membrane oxygenation (ECMO) Alessandro Grandi

Anatomical applicability of current off-the-shelf branched endografts in thoracoabdominal aortic aneurysms managed by open surgery.

The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China

Percutaneous access and closure of the axillary artery during complex aortic endovascular procedures

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Endovascular treatment for pseudoocclusion of the internal carotid artery

ESC Heart & Brain Workshop

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ

New ischemic brain lesions on DW-MRI after CAS with double layer stent

Fast-track CEA: a 3-year experience

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA

Carotid Artery Stenosis

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster

Comparison of Outcomes between Primary Closure vs. Patch Angioplasty in Carotid Endarterectomy

Carotid Intravascular Imaging Technique and Indication

Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers

Carlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis

Will guidelines and clinical practice for asymptomatic stenosis change in the near future?

Impact of the Aortic Arch on Stent Performance

Surgical Procedures for. Symptomatic Post-CAS Carotid. Restenosis: Experiences and. Mid-Term Outcomes. Lefeng Qu M.D., Ph.D. Professor of Surgery

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund

Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie?

RENAL AND MESENTERIC ARTERY STENTS Are There Standard Velocity Criteria for Restenosis?

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Prevention and Management of Cardiac Adverse Event

PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!!

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA

Carotid Disease and CABG: What is the best Treatment

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease?

Quality Measures MIPS CV Specific

Spontaneous embolisation on TCD and carotid plaque features

THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

Chimney endovascular aneurysm sealing (ch-evas) for ruptured abdominal aortic aneurysms (AAA) due to type Ia endoleak following failed EVAS

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

Experience of endovascular procedures on abdominal and thoracic aorta in CA region

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Carotid Artery Stenting

Morphological duplex ultrasound criteria how to assess and report echolucency, inhomogeneity and ulceration

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Endovascular treatment of carotid-jugular fistula after gunshot wound

DETECT-PAD Computerized and patient specific model to determine pressure gradients in borderline iliac artery stenosis with MRA/ CTA

The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Cardiovascular Disease in CLI Patients

PREDICTORS OF PERI-PROCEDURAL OUTCOMES OF CAS A REAL WORLD EXPERIENCE

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)

Internal carotid artery near-total occlusions: Is it justified to operate on them?

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

Limitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion

Natural history of carotid artery occlusion contralateral to carotid endarterectomy

CAS as first line of treatment in the future

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

THE CASE FOR TCAR UNDER LOCAL ANESTHESIA. Sumaira Macdonald MD, PhD Vascular Interventional Radiologist & Chief Medical Officer, Silk Road Medical

Overview of Subclavian & Innominate Artery Interventions

Presente e futuro negli aneurismi dell arco aortico

Registry Assessment of Peripheral Interventional Devices (RAPID)

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

The Auckland Experience with the Nellix EVAS System. Andrew Holden, MBChB, FRANZCR

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France

Impact of Severe Postoperative Complications after Cardiac Surgery on Mortality in Patients Aged over 80 Years

Contemporary management of brachiocephalic occlusive disease. TM Sullivan Minneapolis, MN

How good is current best medical therapy (BMT) for stroke prevention in patients with asymptomatic carotid stenosis?

Emboli detection to evaluate risk of stroke

CEA and cerebral protection Volodymyr labinskyy, MD

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Preoperative Coronary Stenosis Is a Determinant of Early Vascular Outcome after Carotid Endarterectomy

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Disclosures. EVAR follow-up: actual recommendation. EVAR follow-up: critical issues

BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial

Carotid Stenting and Surgery in 2016 in Russia

Francesco Speziale, Laura Capoccia

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

Acute Stroke Management What is State of the Art?

Disclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD

Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm

Introduction. The sirolimus-eluting stents (SES) (Cypher Cordis, Johnson and Johnson, Florida, USA) and paclitaxel-eluting ABSTRACT

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC

P. Paluszek, P. Pieniazek, P. Musialek, T. Przewlocki, L. Tekieli, A. Kablak-Ziembicka, K. Dzierwa, M. Hlawaty, M. Trystula, P.

For the ICSS Investigators. 7 th Munich Vascular Conference Munich, 7 December 2017

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention

Redo treatment and open conversion after TEVAR

Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study

Prise en charge du polyvasculaire

Transcription:

Comarison of carotid artery stenting results in rimary stenosis and ost-surgical restenosis Andrea Sertino, MD Daniele Mascia, MD Vascular Surgery Vita-Salute University San Raffaele Scientific Institute, Milan Italy Chief: Prof. Roberto Chiesa

Disclosure Seaker name: Andrea Sertino, MD I have the following otential conflicts of interest to reort: Consulting Emloyment in industry Stockholder of a healthcare comany Owner of a healthcare comany Other(s) I do not have any otential conflict of interest 2

Carotid artery stenting (CAS) ESVS guidelines 1 ESVS 2009 Symtomatic > 70%, Grade I > 50%, Grade IIa Asymtomatic 70%, Grade I Evidence level A Carotid endarterectomy (CEA) is the gold standard CAS should be erformed only in high-risk for CEA atients 1. Liais CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg. 2009;37(4) Sul:1 19. doi: 10.1016/j.ejvs.2008.11.006. 3

Role of CAS in restenosis Addressed as intervention of choice 2,3 Several studies on CAS for rimary stenosis Lack of evidence on different outcome of CAS on restenosis treatment 4 2. Marques de Marino P, Martinez Loez I, Hernandez Mateo MM, et al. Oen Versus Endovascular Treatment for Patients with Post-Carotid Endarterectomy Restenosis: Early and Long-term Results. Ann Vasc Surg. 2016;36:159-165. doi:10.1016/j.avsg.2016.02.027 3. de Borst GJ, Ackerstaff RGA, de Vries JPPM, et al. Carotid angiolasty and stenting for ostendarterectomy stenosis: Long-term follow-u. J Vasc Surg. 2007;45(1):118-123. doi:10.1016/j.jvs.2006.09.013. 4. AbuRahma AF, Abu-Halimah S, Hass SM, et al. Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for atients with ost-carotid 4 endarterectomy stenosis. J Vasc Surg. 2010;52(5):1180-1187. doi:10.1016/j.jvs.2010.06.074.

Post-CEA restenosis 150.000 CEA are erformed every year in the USA 5 6% to 14% restenosis rate 15.000 restenosis in the USA every year 5.Kim LK, Yang DC et al. Comarison of trends and outcomes of carotid artery stenting and endarterectomy in the United States, 2001 to 2010. Circ Cardiovasc Interv. 2014;7:692 700. doi: 0.1161/CIRCINTERVENTIONS.113.001338. 5

Exerimental design Comarison of CAS in rimary stenosis and restenosis 1. Difference in atients characteristics 2. Intraoerative management 3. Postoerative results 6

Methods 480 atients submitted to CAS from 2008-2016 300 rimary stenosis 180 restenosis 7

Methods Preoerative data 6 (34 items) Demograhic CV risk factors Plaque characteristics Anatomy 6. Timaran CH, McKinsey JF, Schneider PA, Littooy F. Reorting standards for carotid interventions from the Society for Vascular Surgery. J Vasc Surg. 2011;53(6):1679-1695. doi:10.1016/j.jvs.2010.11.122. 8

Methods Intraoerative data (17 items) Drugs administration Surgical rocedure Materials used 9

Methods Postoerative data (14 items) TIA Minor stroke Major stroke Inotroic suort Myocardial infarction Death 10

Statistical analysis T student CHI square Variables Primary Stenosis (n = 300) Restenosis (n = 180) value Age (years) Age (years) 73,83 ± 8,93 73,83 ± 8,93 72,07 ± 7,18 72,07 ± 7,18 0,026 0,026 Gender M 224 (74,66%) 119 (66,11%) 0,044 Gender M 224 (74,66%) 119 (66,11%) 0,044 F 76 (25,34%) 61 (33,89%) F 76 (25,34%) 61 (33,89%) Systolic Systolic Pressure Pressure 135,63 135,63 ± 19,61 19,61 139,67 139,67 ± 18,33 18,33 0,025 0,025 (mmhg) (mmhg) Hyerliidemia Hyerliidemia 245 245 (81,66%) (81,66%) 165 165 (91,66%) (91,66%) 0,003 0,003 Cardiac Cardiac Status Status 141 141 (47%) (47%) 63 63 (35%) (35%) 0,010 0,010 Isilateral stenosis SPV 282,44 ± 84,58 337,43 337,43 ± 107,54 ± 107,54 < 0,001 T Student Test. Chi Square Test 11

Results Preoerative 100% 0.003 Primary Stenosis Restenosis 75% 50% 0.010 25% <0.001 <0.001 0.028 0% Hyerliidaemia Cardiac Disease Tye 3 laque Symtomatic Brain CT-scan 12

100% 0.272 0.035 Results Intraoerative Primary Carotid Stenosis Carotid Restenosis 75% 50% 0.052 <0.001 25% 0.023 0.847 0% Technical Success Carotid Filter 2 Stents Oen Cells Stents Double Layer Stents Atroine 13

Results Postoerative 10% Primary Carotid Stenosis 0.002 Carotid Restenosis 0.041 8% 5% 0.850 3% 0.276 0.620 0.714 0.714 0.881 0% Stroke TIA Cerebral haemorrhage Any Neurologic Event Arrhythmias Inotroic Suort IMA Death 14

Conclusions CAS for carotid ost-cea restenosis safe and effective rocedure lower risk of any neurological events (TIA+stroke) lower risk of erirocedural hemodinamic instability (inotroic suort) 15

Comarison of carotid artery stenting results in rimary stenosis and ost-surgical restenosis Andrea Sertino, MD Daniele Mascia, MD Vascular Surgery Vita-Salute University San Raffaele Scientific Institute, Milan Italy Chief: Prof. Roberto Chiesa